Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, CARDLYTICS, INC. reported revenue of $233M, down 16.2% year over year. Operating margin was -43.6% and net margin -44.4%, on a free-cash-flow margin of 3.8% with capital expenditure at 0.2% of revenue. Every figure is computed directly from CDLX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $233M | -43.6% | -44.4% |
| FY2024 | $278M | -70.2% | -68.0% |
| FY2023 | $309M | -43.9% | -43.6% |
| FY2022 | $299M | -153.3% | -155.8% |
| FY2021 | $267M | -45.9% | -48.1% |
How does CDLX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: ABM · ACIW · ACN · ACVA · ADBE · ADMQ
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.